ANDA 211633, held by Lupin. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 211633 (Extended Phenytoin Sodium), held by Lupin, was first approved by FDA on Sep 30, 2019, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED · capsule;oral | Phenytoin Sodium | Discontinued |
| Apr 15, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Apr 15, 2024 | Supplement 3Labeling · Standard review | Approved | None posted |
| Sep 30, 2019 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters